APO RESEARCH · REPORT
Glycyrrhetinic Acid (CAS 471-53-4)
Glycyrrhetinic Acid (CAS 471-53-4) (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
Product & engineering
Understand the product.
Glycyrrhetinic Acid (CAS 471-53-4) (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
Selected research
Market Outlook & Growth Opportunities
Global Glycyrrhetinic Acid (CAS 471-53-4) Market Outlook and Growth Opportunities 2026
Market perspective
Glycyrrhetinic Acid (CAS 471-53-4) (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
Fujie Pharmaceutical, QHL Pharma, Select Botanical and Tianshan Pharmaceuticals are the leading players in licorice acid (CAS 471-53-4) market, the top 3 accounting for about 48% of the market share.
Asia-Pacific is the largest production region with a market share of about 50%, followed by Europe with about 40%.
Read the full market overview
This report provides an overview of the global Glycyrrhetinic Acid (CAS 471-53-4) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glycyrrhetinic Acid (CAS 471-53-4) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glycyrrhetinic Acid (CAS 471-53-4) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glycyrrhetinic Acid (CAS 471-53-4) market size, projected growth trends, production technologies, key applications, and end-use industries.
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Company
Fujie Pharmaceutical
Qinghai Lake Pharmaceutical
Select Botanical
Givaudan (Indena S.p.A.)
Alchem International
TIANSHAN Pharmaceuticals
GfN & Selco
Jiangshu Tiansheng Pharmaceutical
Gansu Fanzhi Pharmaceutical
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Content
Above 98%
Below 98%
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Application
Pharmaceutical
Cosmetic
Others
Glycyrrhetinic Acid (CAS 471-53-4) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Glycyrrhetinic Acid (CAS 471-53-4) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Glycyrrhetinic Acid (CAS 471-53-4) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Glycyrrhetinic Acid (CAS 471-53-4) significant trends, drivers, influence factors in global and regions.
6. To analyze Glycyrrhetinic Acid (CAS 471-53-4) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycyrrhetinic Acid (CAS 471-53-4) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycyrrhetinic Acid (CAS 471-53-4) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycyrrhetinic Acid (CAS 471-53-4).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glycyrrhetinic Acid (CAS 471-53-4) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glycyrrhetinic Acid (CAS 471-53-4) industry.
Chapter 3: Detailed analysis of Glycyrrhetinic Acid (CAS 471-53-4) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Glycyrrhetinic Acid (CAS 471-53-4) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Glycyrrhetinic Acid (CAS 471-53-4) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Below 98%
Applications
- Pharmaceutical
- Cosmetic
- Others
Companies covered
- Fujie Pharmaceutical
- Qinghai Lake Pharmaceutical
- Select Botanical
- Givaudan (Indena S.p.A.)
- Alchem International
- TIANSHAN Pharmaceuticals
- GfN & Selco
- Jiangshu Tiansheng Pharmaceutical
- Gansu Fanzhi Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value (2021-2032)
- 1.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume (2021-2032)
- 1.2.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Glycyrrhetinic Acid (CAS 471-53-4) Market Dynamics
- 2.1 Glycyrrhetinic Acid (CAS 471-53-4) Industry Trends
- 2.2 Glycyrrhetinic Acid (CAS 471-53-4) Industry Drivers
- 2.3 Glycyrrhetinic Acid (CAS 471-53-4) Industry Opportunities and Challenges
- 2.4 Glycyrrhetinic Acid (CAS 471-53-4) Industry Restraints
3 Glycyrrhetinic Acid (CAS 471-53-4) Market by Company
- 3.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Company Revenue Ranking in 2025
- 3.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Revenue by Company (2021-2026)
- 3.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume by Company (2021-2026)
- 3.4 Global Glycyrrhetinic Acid (CAS 471-53-4) Average Price by Company (2021-2026)
- 3.5 Global Glycyrrhetinic Acid (CAS 471-53-4) Company Ranking (2024-2026)
- 3.6 Global Glycyrrhetinic Acid (CAS 471-53-4) Company Manufacturing Base and Headquarters
- 3.7 Global Glycyrrhetinic Acid (CAS 471-53-4) Company Product Type and Application
- 3.8 Global Glycyrrhetinic Acid (CAS 471-53-4) Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Glycyrrhetinic Acid (CAS 471-53-4) Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Glycyrrhetinic Acid (CAS 471-53-4) Market by Type
- 4.1 Glycyrrhetinic Acid (CAS 471-53-4) Type Introduction
- 4.1.1 Above 98%
- 4.1.2 Below 98%
- 4.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume by Type
- 4.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume by Type (2021-2032)
- 4.2.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume Share by Type (2021-2032)
- 4.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Type
- 4.3.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Type (2021-2032)
- 4.3.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type (2021-2032)
5 Glycyrrhetinic Acid (CAS 471-53-4) Market by Application
- 5.1 Glycyrrhetinic Acid (CAS 471-53-4) Application Introduction
- 5.1.1 Pharmaceutical
- 5.1.2 Cosmetic
- 5.1.3 Others
- 5.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume by Application
- 5.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume by Application (2021-2032)
- 5.2.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Volume Share by Application (2021-2032)
- 5.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Application
- 5.3.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Application (2021-2032)
- 5.3.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application (2021-2032)
6 Glycyrrhetinic Acid (CAS 471-53-4) Regional Sales and Value Analysis
- 6.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Region (2021-2032)
- 6.2.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Region: 2021-2026
- 6.2.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Region (2027-2032)
- 6.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Region (2021-2032)
- 6.4.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Region: 2021-2026
- 6.4.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Region (2027-2032)
- 6.5 Global Glycyrrhetinic Acid (CAS 471-53-4) Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Glycyrrhetinic Acid (CAS 471-53-4) Sales Value (2021-2032)
- 6.6.2 North America Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Glycyrrhetinic Acid (CAS 471-53-4) Sales Value (2021-2032)
- 6.7.2 Europe Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Glycyrrhetinic Acid (CAS 471-53-4) Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Glycyrrhetinic Acid (CAS 471-53-4) Sales Value (2021-2032)
- 6.9.2 South America Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Glycyrrhetinic Acid (CAS 471-53-4) Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Country, 2025 VS 2032
7 Glycyrrhetinic Acid (CAS 471-53-4) Country-level Sales and Value Analysis
- 7.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Country (2021-2032)
- 7.3.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Country (2021-2026)
- 7.3.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales by Country (2027-2032)
- 7.4 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Country (2021-2032)
- 7.4.1 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Country (2021-2026)
- 7.4.2 Global Glycyrrhetinic Acid (CAS 471-53-4) Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.9.2 France Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.16.2 China Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.19.2 India Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Glycyrrhetinic Acid (CAS 471-53-4) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Fujie Pharmaceutical
- 8.1.1 Fujie Pharmaceutical Company Information
- 8.1.2 Fujie Pharmaceutical Business Overview
- 8.1.3 Fujie Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Fujie Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.1.5 Fujie Pharmaceutical Recent Developments
- 8.2 Qinghai Lake Pharmaceutical
- 8.2.1 Qinghai Lake Pharmaceutical Company Information
- 8.2.2 Qinghai Lake Pharmaceutical Business Overview
- 8.2.3 Qinghai Lake Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Qinghai Lake Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.2.5 Qinghai Lake Pharmaceutical Recent Developments
- 8.3 Select Botanical
- 8.3.1 Select Botanical Company Information
- 8.3.2 Select Botanical Business Overview
- 8.3.3 Select Botanical Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Select Botanical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.3.5 Select Botanical Recent Developments
- 8.4 Givaudan (Indena S.p.A.)
- 8.4.1 Givaudan (Indena S.p.A.) Company Information
- 8.4.2 Givaudan (Indena S.p.A.) Business Overview
- 8.4.3 Givaudan (Indena S.p.A.) Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Givaudan (Indena S.p.A.) Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.4.5 Givaudan (Indena S.p.A.) Recent Developments
- 8.5 Alchem International
- 8.5.1 Alchem International Company Information
- 8.5.2 Alchem International Business Overview
- 8.5.3 Alchem International Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Alchem International Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.5.5 Alchem International Recent Developments
- 8.6 TIANSHAN Pharmaceuticals
- 8.6.1 TIANSHAN Pharmaceuticals Company Information
- 8.6.2 TIANSHAN Pharmaceuticals Business Overview
- 8.6.3 TIANSHAN Pharmaceuticals Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.6.4 TIANSHAN Pharmaceuticals Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.6.5 TIANSHAN Pharmaceuticals Recent Developments
- 8.7 GfN & Selco
- 8.7.1 GfN & Selco Company Information
- 8.7.2 GfN & Selco Business Overview
- 8.7.3 GfN & Selco Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.7.4 GfN & Selco Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.7.5 GfN & Selco Recent Developments
- 8.8 Jiangshu Tiansheng Pharmaceutical
- 8.8.1 Jiangshu Tiansheng Pharmaceutical Company Information
- 8.8.2 Jiangshu Tiansheng Pharmaceutical Business Overview
- 8.8.3 Jiangshu Tiansheng Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Jiangshu Tiansheng Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.8.5 Jiangshu Tiansheng Pharmaceutical Recent Developments
- 8.9 Gansu Fanzhi Pharmaceutical
- 8.9.1 Gansu Fanzhi Pharmaceutical Company Information
- 8.9.2 Gansu Fanzhi Pharmaceutical Business Overview
- 8.9.3 Gansu Fanzhi Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Gansu Fanzhi Pharmaceutical Glycyrrhetinic Acid (CAS 471-53-4) Product Portfolio
- 8.9.5 Gansu Fanzhi Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glycyrrhetinic Acid (CAS 471-53-4) Value Chain Analysis
- 9.1.1 Glycyrrhetinic Acid (CAS 471-53-4) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glycyrrhetinic Acid (CAS 471-53-4) Sales Mode & Process
- 9.2 Glycyrrhetinic Acid (CAS 471-53-4) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glycyrrhetinic Acid (CAS 471-53-4) Distributors
- 9.2.3 Glycyrrhetinic Acid (CAS 471-53-4) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst